
Tony Kulesa
Principal
Founding director of MIT Biomakerspace and former instructor in MIT’s biological engineering department. Holds a PhD from MIT, where he developed innovative platforms for drug discovery. He was also a founding officer of the MIT Biotech Group and co-created courses on biotech entrepreneurship.
Investor scope
Investment criteria breakdown.
Investment stages
Pre-Seed
Seed
Series A
Target regions
USA
Investment ranges
$0 - $100K
$100K - $500K
$500K - $1M
$1M - $3M
$3M - $10M
Focus areas
Biotech
Web3
Health
Related unicorns
A glimpse at some of the $1B+ valuation companies backed by this fund.